Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay

Journal of Lipid Research

Volumn 56, Issue 7, 2015, Pages 1363-1369

  De Barros, Jean Paul Pais ^a,b,c   Gautier, Thomas ^a,b,c   Sali, Wahib ^a,b,c   Adrie, Christophe ^d   Choubley, Hélène ^c   Charron, Emilie ^c   Lalande, Caroline ^c   Le Guern, Naig ^a,b,c   Deckert, Valérie ^a,b,c   Monchi, Mehran ^e   Quenot, Jean Pierre ^a,b,c,f   Lagrost, Laurent ^a,b,c,f  

^a Chu   (France)

^b UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

^c LipSTIC LabEx   (France)

^d Paris University ^*  (France)

^e Department of Intensive Care Medicine   (France)

^f DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Diagnostic tool; Human; Inflammation; Lipid transfer protein; Lipoprotein; Liquid chromatography tandem mass spectrometry; Mass spectrometry; Mouse; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

3 HYDROXYMYRISTATE; CHEMICAL COMPOUND; LIPOPOLYSACCHARIDE; LIPOPROTEIN; ORGANIC SOLVENT; PHOSPHOLIPID TRANSFER PROTEIN; UNCLASSIFIED DRUG; ENDOTOXIN BINDING PROTEINS; MEMBRANE PROTEIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IN VIVO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIMULUS LYSATE TEST; LIPOPROTEIN BLOOD LEVEL; MALE; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; BLOOD; BLOOD ANALYSIS; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSESHOE CRAB; METABOLISM; MIDDLE AGED; PROCEDURES; TANDEM MASS SPECTROMETRY;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HORSESHOE CRABS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; MICE; MIDDLE AGED; TANDEM MASS SPECTROMETRY;

EID: 84937112190     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D059725     Document Type: Article

References (41)

1. Vincent, J. L., S. M. Opal, J. C. Marshall, and K. J. Tracey. 2013. Sepsis definitions: time for change. Lancet. 381: 774-775.
2. Fitting, C., M. Parlato, M. Adib-Conquy, N. Memain, F. Philippart, B. Misset, M. Monchi, J. M. Cavaillon, and C. Adrie. 2012. DNAemia detection by multiplex PCR and biomarkers for infection in systemic inflammatory response syndrome patients. PLoS ONE. 7: e38916.
3. Gibot, S., M. C. Béné, R. Noel, F. Massin, J. Guy, A. Cravoisy, D. Barraud, M. De Carvalho Bittencourt, J. P. Quenot, P. E. Bollaert, et al. 2012. Combination biomarkers to diagnose sepsis in the critically ill patient. Am. J. Respir. Crit. Care Med. 186: 65-71.
4. Quenot, J. P., C. Binquet, F. Kara, O. Martinet, G. F. Ganster, J. C. Navellou, V. Castelain, D. Barraud, J. Cousson, G. Louis, et al. 2013. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit. Care. 17: R65.
5. Beutler, B., and E. T. Rietschel. 2003. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3: 169-176.
6. Das, A. P., P. S. Kumar, and S. Swain. 2014. Recent advances in biosensor based endotoxin detection. Biosens. Bioelectron. 51: 62-75.
7. Schindler, S., I. Spreitzer, B. Löschner, S. Hoffmann, K. Hennes, M. Halder, P. Brügger, E. Frey, T. Hartung, and T. Montag. 2006. International validation of pyrogen tests based on cryopreserved human primary blood cells. J. Immunol. Methods. 316: 42-51.
8. Maitra, S. K., M. C. Schotz, T. T. Yoshikawa, and L. B. Guze. 1978. Determination of lipid A and endotoxin in serum by mass spectroscopy. Proc. Natl. Acad. Sci. USA. 75: 3993-3997.
9. Marshall, J. C., P. M. Walker, D. M. Foster, D. Harris, M. Ribeiro, J. Paice, A. D. Romaschin, and A. N. Derzko. 2002. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit. Care. 6: 342-348.
10. Brandtzaeg, P., K. Bryn, P. Kierulf, R. Øvstebø, E. Namork, B. Aase, and E. Jantzen. 1992. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography-mass spectrometry, ultracentrifugation and electron microscopy. J. Clin. Invest. 89: 816-823.
11. Szponar, B., L. Kras'nik, T. Hryniewiecki, A. Gamian, and L. Larsson. 2003. Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin. Clin. Chem. 49: 1149-1153.
12. Jiang, X. C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20: 864-874.
14. Gautier, T., A. Klein, V. Deckert, C. Desrumaux, N. Ogier, A. L. Sberna, C. Paul, N. Le Guern, A. Athias, T. Montange, et al. 2008. Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice. J. Biol. Chem. 283: 18702-18710.
15. Zehethofer, N., D. M. Pinto, and D. A. Volmer. 2008. Plasma free fatty acid profiling in a fish oil human intervention study using ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 22: 2125-2133.
16. Munford, R. S., and A. W. Varley. 2006. Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria. PLoS Pathog. 2: e67.
17. Cohen, J. 2000. The detection and interpretation of endotoxaemia. Intensive Care Med. 26: S51-S56.
18. Read, T. E., H. W. Harris, C. Grunfeld, K. R. Feingold, M. C. Calhoun, J. P. Kane, and J. H. Rapp. 1993. Chylomicrons enhance endotoxin excretion in bile. Infect. Immun. 61: 3496-3502.
19. Rood, J., and S. R. Smith. 2008. Triglyceride concentrations and endotoxemia. Am. J. Clin. Nutr. 88: 248-249.
20. Emancipator, K., G. Csako, and R. J. Elin. 1992. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 60: 596-601.
21. Szponar, B., E. Norin, T. Midtvedt, and L. Larsson. 2002. Limitations in the use of 3-hydroxy fatty acid analysis to determine endotoxin in mammalian samples. J. Microbiol. Methods. 50: 283-289.
22. Maitra, S. K., R. Nachum, and F. C. Pearson. 1986. Establishment of β-hydroxy fatty acids as chemical marker molecules for bacterial endotoxin by gas chromatography-mass spectrometry. Appl. Environ. Microbiol. 52: 510-514.
23. Cani, P. D., J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56: 1761-1772.
24. Nguyen, A. T., S. Mandard, C. Dray, V. Deckert, P. Valet, P. Besnard, D. J. Drucker, L. Lagrost, and J. Grober. 2014. Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: involvement of the GLP-1 pathway. Diabetes. 63: 471-482.
25. Fink, P. C., L. Lehr, R. M. Urbaschek, and J. Kozak. 1981. Limulus amebocyte lysate test for endotoxemia: investigations with a femtogram sensitive spectrophotometric assay. Klin. Wochenschr. 59: 213-218.
26. Balagopal, A., L. Gama, V. Franco, J. N. Russell, J. Quinn, Y. Higgins, L. M. Smeaton, J. E. Clements, D. L. Thomas, and A. Gupta. 2012. Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma. PLoS ONE. 7: e41258.
27. Levin, J., P. A. Tomasulo, and R. S. Oser. 1970. Detection of endotoxin in human blood and demonstration of an inhibitor. J. Lab. Clin. Med. 75: 903-911.
28. Hurley, J. C., F. A. Tosolini, and W. J. Louis. 1991. Quantitative Limulus lysate assay for endotoxin and the effect of plasma. J. Clin. Pathol. 44: 849-854.
29. Rauchhaus, M., A. J. Coats, and S. D. Anker. 2000. The endotoxin-lipoprotein hypothesis. Lancet. 356: 930-933.
30. Gautier, T., and L. Lagrost. 2011. Plasma PLTP (phospholipid-transfer protein): an emerging role in 'reverse lipopolysaccharide transport' and innate immunity. Biochem. Soc. Trans. 39: 984-988.
31. Duheron, V., M. Moreau, B. Collin, W. Sali, C. Bernhard, C. Goze, T. Gautier, J. P. Pais de Barros, V. Deckert, F. Brunotte, et al. 2014. Dual labeling of lipopolysaccharides for SPECT-CT imaging and fluorescence microscopy. ACS Chem. Biol. 9: 656-662.
32. Stumacher, R. J., M. J. Kovnat, and W. R. McCabe. 1973. Limitations of the usefulness of the Limulus assay for endotoxin. N. Engl. J. Med. 288: 1261-1264.
33. Bates, D. W., J. Parsonnet, P. A. Ketchum, E. B. Miller, T. J. Novitsky, K. Sands, P. L. Hibberd, P. S. Graman, P. N. Lanken, J. S. Schwartz, et al.; AMCC Sepsis Project Working Group. 1998. Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. Clin. Infect. Dis. 27: 582-591.
34. Feldman, S., and T. A. Pearson. 1974. The Limulus test and gram-negative bacillary sepsis. Am. J. Dis. Child. 128: 172-174.
35. Danner, R. L., R. J. Elin, J. M. Hosseini, R. A. Wesley, J. M. Reilly, and J. E. Parillo. 1991. Endotoxemia in human septic shock. Chest. 99: 169-175.
36. Ikeda, T., K. Ikeda, S. Suda, and T. Ueno. 2014. Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients. Innate Immun. 20: 881-887.
37. Hurley, J. C. 1995. Reappraisal with meta-analysis of bacteremia, endotoxemia, and mortality in gram-negative sepsis. J. Clin. Microbiol. 33: 1278-1282.
38. Wilkinson, S. P., H. Moodie, J. D. Stamatakis, V. V. Kakkar, and R. Williams. 1976. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br. Med. J. 2: 1415-1418.
39. Caradonna, L., L. Amati, T. Magrone, N. M. Pellegrino, E. Jirillo, and D. Caccavo. 2000. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin Res. 6: 205-214.
40. Kallio, K. A., K. Buhlin, M. Jauhiainen, R. Keva, A. M. Tuomainen, B. Klinge, A. Gustaffson, and P. J. Pussinen. 2008. Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients. Innate Immun. 14: 247-253.
41. Vergès, B., L. Duvillard, L. Lagrost, C. Vachoux, C. Garret, K. Bouyer, M. Courtney, C. Pomié, and R. Burcelin. 2014. Changes in lipoprotein kinetics associated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins. J. Clin. Endocrinol. Metab. 99: E1245-E1253.